AllianceBernstein’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.31M | Sell |
28,213
-30,367
| -52% | -$4.55M | ﹤0.01% | 1621 |
|
|
2026
Q1 | $8.08M | Buy |
58,580
+47,267
| +418% | +$7.25M | ﹤0.01% | 1303 |
|
|
2025
Q4 | $1.56M | Sell |
11,313
-62,769
| -85% | -$8.22M | ﹤0.01% | 2135 |
|
|
2025
Q3 | $9.5M | Buy |
74,082
+2,110
| +3% | +$257K | ﹤0.01% | 1229 |
|
|
2025
Q2 | $8.71M | Sell |
71,972
-36,753
| -34% | -$4.14M | ﹤0.01% | 1234 |
|
|
2025
Q1 | $12.1M | Buy |
108,725
+61,567
| +131% | +$6.55M | ﹤0.01% | 1072 |
|
|
2024
Q4 | $4.59M | Buy |
47,158
+12,184
| +35% | +$1.3M | ﹤0.01% | 1530 |
|
|
2024
Q3 | $4.02M | Buy |
34,974
+12,367
| +55% | +$1.4M | ﹤0.01% | 1611 |
|
|
2024
Q2 | $2.41M | Sell |
22,607
-30,176
| -57% | -$3.03M | ﹤0.01% | 1841 |
|
|
2024
Q1 | $5.11M | Sell |
52,783
-7,347
| -12% | -$753K | ﹤0.01% | 1454 |
|
|
2023
Q4 | $6.07M | Buy |
60,130
+7,703
| +15% | +$744K | ﹤0.01% | 1407 |
|
|
2023
Q3 | $5.34M | Buy |
52,427
+20,220
| +63% | +$2.05M | ﹤0.01% | 1387 |
|
|
2023
Q2 | $3.25M | Buy |
32,207
+6,328
| +24% | +$633K | ﹤0.01% | 1627 |
|
|
2023
Q1 | $2.38M | Sell |
25,879
-869
| -3% | -$75.9K | ﹤0.01% | 1773 |
|
|
2022
Q4 | $2.43M | Buy |
26,748
+181
| +0.7% | +$15.2K | ﹤0.01% | 1802 |
|
|
2022
Q3 | $2.02M | Buy |
26,567
+554
| +2% | +$45.9K | ﹤0.01% | 1882 |
|
|
2022
Q2 | $2.2M | Sell |
26,013
-2,104
| -7% | -$185K | ﹤0.01% | 1900 |
|
|
2022
Q1 | $2.47M | Sell |
28,117
-800
| -3% | -$69.3K | ﹤0.01% | 1960 |
|
|
2021
Q4 | $2.53M | Sell |
28,917
-154
| -0.5% | -$12.8K | ﹤0.01% | 2000 |
|
|
2021
Q3 | $2.38M | Sell |
29,071
-230
| -0.8% | -$20.7K | ﹤0.01% | 2061 |
|
|
2021
Q2 | $2.67M | Sell |
29,301
-44,546
| -60% | -$3.97M | ﹤0.01% | 2008 |
|
|
2021
Q1 | $6.31M | Buy |
73,847
+41,805
| +130% | +$3.75M | ﹤0.01% | 1435 |
|
|
2020
Q4 | $3.03M | Buy |
32,042
+869
| +3% | +$75.9K | ﹤0.01% | 1752 |
|
|
2020
Q3 | $2.71M | Buy |
31,173
+1,296
| +4% | +$112K | ﹤0.01% | 1675 |
|
|
2020
Q2 | $2.61M | Buy |
29,877
+1,038
| +4% | +$89.6K | ﹤0.01% | 1700 |
|
|
2020
Q1 | $2.38M | Sell |
28,839
-694
| -2% | -$61.9K | ﹤0.01% | 1580 |
|
|
2019
Q4 | $2.8M | Buy |
29,533
+428
| +1% | +$38.4K | ﹤0.01% | 1775 |
|
|
2019
Q3 | $2.53M | Buy |
29,105
+630
| +2% | +$56.6K | ﹤0.01% | 1787 |
|
|
2019
Q2 | $2.6M | Sell |
28,475
-98,392
| -78% | -$8.33M | ﹤0.01% | 1809 |
|
|
2019
Q1 | $10.9M | Buy |
126,867
+26,502
| +26% | +$2.13M | 0.01% | 1021 |
|
|
2018
Q4 | $7.72M | Sell |
100,365
-85,178
| -46% | -$6.63M | 0.01% | 1101 |
|
|
2018
Q3 | $14.3M | Buy |
185,543
+127,579
| +220% | +$9.43M | 0.01% | 874 |
|
|
2018
Q2 | $3.92M | Sell |
57,964
-1,531
| -3% | -$106K | ﹤0.01% | 1421 |
|
|
2018
Q1 | $4.31M | Sell |
59,495
-1,295
| -2% | -$98.6K | ﹤0.01% | 1304 |
|
|
2017
Q4 | $4.57M | Sell |
60,790
-19,473
| -24% | -$1.47M | ﹤0.01% | 1267 |
|
|
2017
Q3 | $6.17M | Buy |
80,263
+17,205
| +27% | +$1.3M | ﹤0.01% | 1119 |
|
|
2017
Q2 | $4.72M | Buy |
63,058
+1,655
| +3% | +$117K | ﹤0.01% | 1247 |
|
|
2017
Q1 | $4.09M | Buy |
61,403
+15,714
| +34% | +$1.05M | ﹤0.01% | 1316 |
|
|
2016
Q4 | $2.98M | Sell |
45,689
-1,912
| -4% | -$124K | ﹤0.01% | 1550 |
|
|
2016
Q3 | $3.37M | Buy |
47,601
+9,358
| +24% | +$682K | ﹤0.01% | 1384 |
|
|
2016
Q2 | $2.83M | Buy |
38,243
+5,406
| +16% | +$373K | ﹤0.01% | 1423 |
|
|
2016
Q1 | $2.13M | Buy |
32,837
+6,619
| +25% | +$450K | ﹤0.01% | 1561 |
|
|
2015
Q4 | $2.02M | Sell |
26,218
-8,583
| -25% | -$682K | ﹤0.01% | 1609 |
|
|
2015
Q3 | $2.87M | Sell |
34,801
-16,506
| -32% | -$1.47M | ﹤0.01% | 1376 |
|
|
2015
Q2 | $4.52M | Buy |
51,307
+11,935
| +30% | +$1.09M | ﹤0.01% | 1167 |
|
|
2015
Q1 | $3.48M | Buy |
39,372
+4,940
| +14% | +$438K | ﹤0.01% | 1334 |
|
|
2014
Q4 | $2.86M | Buy |
34,432
+74
| +0.2% | +$6.13K | ﹤0.01% | 1470 |
|
|
2014
Q3 | $2.9M | Sell |
34,358
-5,349
| -13% | -$433K | ﹤0.01% | 1437 |
|
|
2014
Q2 | $3.22M | Sell |
39,707
-475
| -1% | -$37.4K | ﹤0.01% | 1415 |
|
|
2014
Q1 | $3.06M | Sell |
40,182
-3,493
| -8% | -$255K | ﹤0.01% | 1411 |
|
|
2013
Q4 | $3.15M | Buy |
43,675
+373
| +0.9% | +$25.9K | ﹤0.01% | 1406 |
|
|
2013
Q3 | $2.98M | Buy |
43,302
+6,939
| +19% | +$459K | ﹤0.01% | 1396 |
|
|
2013
Q2 | $2.3M | Buy |
+36,363
| New | +$2.37M | ﹤0.01% | 1512 |
|
Other funds holding NVS
AllianceBernstein's NVS Position: Q2 2026 in Review
AllianceBernstein reduced its Novartis (NVS) stake by 52% in Q2 2026, selling an estimated $4.55M and leaving 28,213 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1621.
AllianceBernstein first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.3M in Q3 2018. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- AllianceBernstein held 28,213 shares of Novartis worth $4.31M as of Q2 2026.
- AllianceBernstein sold 30,367 Novartis shares in Q2 2026, an estimated $4.55M.
- Novartis made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1621 holding.
- AllianceBernstein first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- AllianceBernstein's Novartis position peaked at $14.3M in Q3 2018.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.